x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Sep 22, 2016 2:46 PM ET

Archived: NovaScan LLC has developed a technology that detects cancer real time in human tissue, both ex vivo and in vivo

iCrowdNewswire - Sep 22, 2016

NovaScan LLC

Milwaukee, WI 53233, US
Medical Devices & Equipment
www.novascan

NovaScan LLC Logo

NovaScan LLC has developed a technology that detects cancer real time in human tissue, both ex vivo and in vivo. Our first target disease is breast cancer, and recently we have investigated the use of this technology for skin cancer, with other types of cancer to follow (such as thyroid cancer).
There are currently two devices in development: a hand-held probe (FastPath™) and an Electrical Anomaly Mammogram (EAM), These devices have demonstrated excellent precision in clinical studies and are being further tested to bring them to market.

Products / Services

FastPath Probe and Electrical Mammogram

NovaScan LLC has developed a technology that detects cancer real time in human tissue, both ex vivo and in vivo. Our first target disease is breast cancer, and recently we have investigated the use of this technology for skin cancer, with other types of cancer to follow (such as thyroid cancer).
There are currently two devices in development: a hand-held probe (FastPath™) and an Electrical Anomaly Mammogram (EAM), These devices have demonstrated excellent precision in clinical studies and are being further tested to bring them to market.

 

Management

Science/Scientist
Dr. William Gregory

Summary

Prior Year RevenueCurrent Year RevenueNext Year Revenue

 

Company AgeEmployeesSub-Industry
11 years, 8 months3Surgical

 

Company TypeStock ExchangeStock Symbol
Privately-Held
Contact Information:

Sean Gregory

View Related News >